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Abstract

Biodegradable magnesium alloys are advantageous in various implant applications, as they reduce the risks
associated with permanent metallic implants. However, a rapid corrosion rate is usually a hindrance in
biomedical applications. Here we report a facile two step procedure to introduce multifunctional, anticorrosive coatings on Mg alloys, such as AZ31. The first step involves treating the NaOH-activated Mg with
bistriethoxysilylethane to immobilize a layer of densely crosslinked silane coating with good corrosion
resistance; the second step is to impart amine functionality to the surface by treating the modified Mg with
3-amino-propyltrimethoxysilane. We characterized the two-layer anticorrosive coating of Mg alloy AZ31 by
Fourier transform infrared spectroscopy, static contact angle measurement and optical profilometry,
potentiodynamic polarization and AC impedance measurements. Furthermore, heparin was covalently
conjugated onto the silane-treated AZ31 to render the coating haemocompatible, as demonstrated by reduced
platelet adhesion on the heparinized surface. The method reported here is also applicable to the preparation of
other types of biofunctional, anti-corrosive coatings and thus of significant interest in biodegradable implant
applications.
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Abstract
Biodegradable magnesium (Mg) alloys are advantageous in various implant applications, as
they reduce the risks associated with permanent metallic implants. However, the fast
corrosion rate is usually a hindrance in biomedical applications. Here we report a facile twostep procedure to introduce multifunctional, anticorrosive coatings on Mg alloys, such as
AZ31. The first step involves treating the NaOH-activated Mg with bistriethoxysilylethane
(BTSE) to immobilise a layer of densely crosslinked silane coating with good corrosion
resistance; the second step is to impart amine functionality to the surface by treating the
modified Mg with 3-amino-propyltrimethoxysilane (γ-APS). We characterised the two-layer
anticorrosive coating of AZ31 Mg alloy by Fourier transform infrared spectroscopy, static
contact angle measurement and optical profilometry, potentiodynamic polarization and AC
impedance measurements. Furthermore, heparin was covalently conjugated onto the silane
treated AZ31 to render the coating haemocompatible, as demonstrated by reduced platelet
adhesion on the heparinised surface. The method reported here is also applicable to the
preparation of other types of biofunctional, anticorrosive coatings, and thus of significant
interest in biodegradable implant applications.

Keywords: Magnesium alloy; heparin; silane; corrosion; biodegradable metallic implants;
platelet adhesion
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Introduction
Metallic implants, such as stents, bone plates and artificial joints, are widely used in the
human body. However, there are serious problems associated with permanent metallic
implants, including restenosis, thrombosis, physical irritation, potential inflammatory
responses and inability to adapt to the growth and changes of the human body [1]. In some
cases, additional surgery is required to remove the implant after the tissue has sufficiently
healed [2] and, as a consequence, researchers and clinicians are looking towards
biodegradable implants that, once implanted, only remain for an appropriate period to “fix”
the problem and then disappear [3]. Coupled with their strong mechanical properties and
low cytotoxicity, magnesium (Mg) alloys have attracted increasing attention as candidate
materials for biodegradable stents and bone plates [1, 4-6]. However, the potential clinical
applications of Mg alloys have been hindered by their poor corrosion resistance. Fast
corrosion of Mg alloys results in the generation of hydrogen bubbles and pH changes, which
will damage surrounding tissues [7]. More seriously, fast corrosion can lead to early loss of
mechanical stability of the Mg alloy implant before the end of the healing process [4].
Therefore, an appropriate corrosion rate becomes an essential requirement for the clinical
applications of Mg alloys in biodegradable metallic implants.
To improve the corrosion resistance of Mg alloys, several techniques have been employed,
including development of new Mg alloys [8, 9], surface modification via nitrogen ion
implantation [10, 11], anodizing [12], and the use of conversion coatings [13-15]. Among
these technologies, silane based anticorrosive coatings of Mg alloys have been proven to be
effective, economical and environmentally benign [16, 17]. Silanes are a group of siliconbased organic-inorganic materials with the general formula R’(CH2)nSi(OR)3, where R’ is an
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organofunctional group and R is a hydrolysable alkoxy group. When in contact with water,
silanes hydrolyse to yield silanol groups (SiOH) that permit attachment to hydrated metal
surfaces (Metal-OH) via the formation of Si-O-metal bonds [18]. In the meantime, the silanol
groups undergo self-crosslinking via siloxane bonds (Si-O-Si), resulting in an organic
protective layer chemically bound to the metallic substrates [19, 20].
Bistriethoxysilylethane (BTSE) and 3-amino-propyltrimethoxysilane (γ-APS) are widely
studied bis-silane and mono-silanes, respectively. Such silanes can provide functional
moieties that enable further attachment of bioactive molecules to enhance the interfacial
properties of metal implants with surrounding cells and tissue [21]. However, it is reported
that the amino group of γ-APS preferentially bonds to metal surfaces, which results in
defects in the silane coatings, thus allowing water to penetrate to the silane-metal interface
[22, 23]. Compared to functional mono-silanes, non-functional “bis-silanes” provide better
corrosion protection due to the formation of densely crosslinked 3D polysiloxane networks
and stronger interfacial adhesion at various metal surfaces, including steel, Al alloy, Cu alloy,
and Mg alloy [24]. To take advantage of both types of silanes, a two-step BTSE-γ-APS coating
treatment has been developed by Van Ooij’s group to provide good corrosion protection for
aluminium and steel [25]. However, to our knowledge, this two-step silane coating has not
been applied to Mg alloys.
Another key requirement for biodegradable metallic implants, especially for cardiovascular
stents, is blood compatibility. Adhesion of platelets can induce thrombus formation and,
consequently, implant failure [26]. Heparin remains the most frequently used anticoagulant
reagent. Surface modification with heparin has been intensively explored for increasing the
thromboresistance of biomedical implants. Previous studies demonstrated that heparin
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coated stents reduced stent thrombosis [27, 28], and resulted in favourable event-free
survival after 6 months [27].
In this study, we developed a two-step BTSE-γ-APS coating strategy to produce a
biofunctionalised anticorrosive coating on AZ31 Mg alloy. The silane layer was analysed
using FTIR and optical profilometry; the anticorrosion properties of the coating was assessed
by potentiodynamic polarization and AC impedance measurements. We also demonstrated
that bioactive heparin can be covalently attached to the silane modified Mg alloy surface.
Using this technology, we demonstrated both markedly improved corrosion resistance and
blood compatibility of the resulting Mg alloy.
Materials and Methods:
Materials
All

reagents

were

propyltrimethoxysilane

used

as

(γ-APS),

received.

Bistriethoxysilylethane

N-hydroxysuccinimide

(BTSE),

(NHS),

3-Amino-

1-ethyl-3-(3-

dimethylaminopropyl) carbodiimide (EDC), 2-morpholinoethanesulfonic acid (MES), heparin,
phosphate buffered saline (PBS), toluidine blue O (TBO) and glutaraldehyde were from
Sigma-Aldrich, Australia. AZ31 Mg alloy sheet with the nominal mass composition of 96%
Mg, 3% Al and 1% Zn was purchased from Goodfellow Metals, UK. Simulated body fluid
(SBF) solution was freshly prepared which contained 5.403 g NaCl, 0.504 g NaHCO3, 0.426 g
Na2CO3, 0.225 g KCl, 0.230 g K2HPO4·3H2O, 0.311g MgCl2·6H2O, 0.8 g NaOH, 17.892 g HEPES,
0.293 g CaCl2 and 0.072 g Na2SO4 in 1000 ml Milli-Q water.
Silanization of AZ31 Mg alloy
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The 2.0 mm thick AZ31 Mg alloy sheets were cut into 15 mm × 20 mm pieces and polished
with progressively fine SiC papers up to grit 2000. The samples were ultrasonically cleaned
using acetone, dried in air, and then immersed in a 3.0 M NaOH solution for 2 h to produce
a uniform hydroxide layer on the substrates. The NaOH-activated Mg substrates are
referred to as Mg-OH.
BTSE or γ-APS solution was prepared by mixing 5 % silane, 90 % ethanol and 5 % MilliQ
water. The solutions were stirred at room temperature (RT) for 1 h to allow the hydrolysis to
proceed. AZ31 samples were then immersed in the hydrolysed BTSE solution at RT for 1 h,
dried with hot air, and then cured at 120 ˚C for 1 h. For the second step coating, the BTSE
treated samples, denoted as Mg-B, were soaked in the γ-APS solution at RT for 30 min
before being cured at 120 ˚C for 1 h. The resultant samples were denoted as Mg-B-A.
Surface modification of Mg-B-A with heparin
EDC•HCl and NHS were added to a heparin solution (5.0 mg/ml) in MES buffer to a final
concentration of 2.0 mg/ml. Mg-B-A samples were immersed in the above solution and
shaken at RT for 4 h. The heparinised samples (Mg-B-A-Heparin) were rinsed 5 times in both
PBS and then water, respectively.
Physiochemical characterisation of the modified AZ31 samples
The surface modified ZA31 samples were investigated using a SHIMADZU IRPrestige-21
Fourier transform infrared spectrophotometer. Attenuated total reflection Fourier
transform infrared (ATR-FTIR) spectra were recorded at a resolution of 4.0 cm-1 and a scan
range of 2000 cm-1 to 700 cm-1. The surface morphology was analysed using a Veeco optical
profiler NT9000 (Veeco Instruments Inc. USA). Static water contact angles were measured
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using the sessile drop method (2.0 µL, Milli Q water) with a Dataphysics OCA20 Goniometer
(DataPhysics Instruments GmbH, Germany).
The amounts of surface accessible heparin were quantified using a TBO assay [29, 30]. In
general, AZ31 samples were immersed in a freshly prepared TBO solution (0.04 wt% in 0.01
M HCl/0.2 wt% NaCl solution, 2.0 ml per sample) and shaken gently at RT for 4 h followed by
rinsing five times with MilliQ water. Then the AZ31 samples were soaked in ethanol/NaOH
(4/1 v/v) solution for 10 min, and the released TBO was quantified by measuring the optical
density of the solution at 530 nm. A standard curve was established using a series of
standard solutions of heparin.
Anticorrosion properties of modified AZ31 sample
Potentiodynamic polarization curves were recorded at a scan rate of 5.0 mV/s in SBF using a
CHI 660 system (CH Instruments, Inc. USA). Electrochemical impedance spectroscopy (EIS)
measurements were carried out in SBF solution using a three electrode cell comprising of a
1.0 cm2 modified AZ31 as the working electrode, a platinum mesh auxiliary electrode and
Ag|AgCl (3.0 M NaCl) reference electrode. The samples were placed in electrolyte and the
open circle potential monitored for 1h. Impedance spectroscopy was conducted between
0.05 Hz and 100 kHz at the measured open-circuit potential with an AC amplitude of 10 mV
using a Gamry Potentiostatic PCI 750 system (Gamry Instruments, USA). The long term
immersion experiments were performed at 37℃, the samples were then removed and the
electrochemical measurement performed at room temperature (24℃).
Platelet adhesion analysis
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Fresh whole rat blood, with EDTA as anticoagulant was obtained from Australia Animal
Resources Centre. The blood samples were centrifuged at 300×g for 10 minutes at RT to
isolate platelet rich plasma (PRP). After removal of the PRP, the remaining samples were
centrifuged at 2500xg for 10 min at RT to isolate platelet pool plasma (PPP). The number of
platelets in the PRP was diluted to 1×108 cells/ml by mixing PRP with PPP. Modified AZ31
samples were immersed into PRP for 1 h at 37˚C. Thereafter, the samples were rinsed twice
with PBS, fixed with 2% glutaraldehyde for 2 h, dehydrated in a series of increasing
concentrations of ethanol to 100 per cent, and then observed using a JEOL 7500FA FESEM.
Statistical analysis
All data are expressed as mean ± SD, unless specified; an unpaired student’s t-test was used
for comparison, and a p-value of less than 0.05 was considered to be statistically significant.
Results and discussion:
Surface modification of AZ31 Mg alloy
The surface modification scheme for AZ31 Mg alloy is shown in Figure 1. To facilitate silane
coating, AZ31 Mg alloy was pre-treated with NaOH to generate surface hydroxide groups
(Mg-OH); BTSE and γ-APS were hydrolysed to yield silanol groups. Mg-OH was then
sequentially treated with the hydrolysed BTSE and γ-APS to introduce a two-layer silane
coating through oxane bond formation with elimination of water. These processes are
accompanied by in situ polycondensation of the hydrolysed BSTE and γ-APS to form the
polysiloxane networks with surface amine functionality. In this study, heparin was employed
as an example of bioactive molecules, and conjugated onto the aminized silane coating of
AZ31 Mg alloy to improve the substrate’s blood compatibility.
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FTIR spectrum (Figure 2) clearly show peaks around 1045-1127 cm-1 that correspond to the
Si-O asymmetric stretching in -Si-O-Si- [19, 25]. Subsequent coating with γ-APS significantly
increases the intensities of these peaks, with the appearance of a new peak around 1570
cm-1 that is assigned to the protonated amino groups [25]. Our FTIR results are consistent
with those reported for BTSE and/or γ-APS treated Al, Fe and Mg samples [17, 19, 25, 31].

Physiochemical properties of the surface modified AZ31 Mg alloys
The influence of modification on the surface morphology of the Mg alloys was investigated
(Figure 3). Bare AZ31 sample showed a uniformly patterned morphology associated with the
polishing procedure, with surface roughness (Ra) of 148.7±16.5 nm (Table 1). Mg-OH still
retained the polishing-induced regular pattern, but with increased Ra of 203.1±6.5 nm. A
much rougher surface morphology (Ra ≈ 910.3±2.2) was noted for Mg-B, attributable to the
BTSE coating. The subsequent modification with γ-APS markedly reduced the Ra of Mg-B-A
to 761.7±51.2 nm, and this is presumably due to the existence of the grafted γ-APS as an
overlayer on the modified AZ31 surface. Further conjugation of heparin onto Mg-B-A
resulted in the roughest surface morphology amongst the tested samples, with a Ra of
2320±57.7 nm. During the two-step silane coating and heparin modification, the polishinginduced regular pattern that is evident on bare AZ31 becomes less distinctive.
The influence of modification is also reflected in the changes in surface wettability of the
modified AZ31 alloys, as characterised by static contact angle measurement (Figure 4). Bare
AZ31 exhibits surface hydrophobicity, with a contact angle of 75.2±2.0˚. The pre-treatment
with NaOH increased the surface hydrophilicity of Mg-OH, giving a water contact angle of
14.4±1.9˚. As expected, incorporation of the BTSE layer re-established the surface
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hydrophobicity, with the static contact angle increasing to 103.2±1.8˚. Compared to Mg-B,
Mg-B-A is less hydrophobic with a lower contact angle of 78.2±1.5˚, ascribed to the
presence of surface amine moieties. Further modification with heparin rendered the surface
hydrophilic [32], as characterised by a much lower water contact angle of 21.4±2.2˚.

Corrosion resistance properties of the modified AZ31 Mg alloys
Functional silanes, such as γ-APS, have often been used for modification of stainless steel
[33] and Ti [30, 34] to provide surface functionality for post chemical anchorage of
biomolecules (e.g. collagen, heparin and fibronectin), with a view to improving the
biocompatibility of these metallic implants. However, functional silanes, such as γ-APS, have
failed to provide effective corrosion resistance for metals and their alloys [24]. As reported
by others [24, 25], there are two regions within a silane coating which can provide corrosion
resistance: the crosslinked outer silane layer enriched with Si-O-Si bonds and the interfacial
layer dominated by Si-O-metal bonds. The more hydrophobic the outer layer, the lower the
water penetration rate [25]. As a bis-silane such as BTSE is more hydrophobic than γ-APS,
and the interfacial regions between bis-silane and metal contains a higher density of Si-Ometal bonds than that of a mono-silane, BTSE provides better corrosion protection than γAPS at both the outer layer and the interfacial layer. Silanes have been widely used as
coupling agents in clinical applications for more than 50 years, particularly in dentistry as
adhesion promoters [35]. They have proven to be safe in vivo [35, 36]. However, the
applications of silane coatings in dentistry are limited by bond degradation [35] associated
with the hydrolytic cleaving of the siloxane bonds. In this works for degradable implant
applications, the purpose of the silane coatings is to slow down the initial corrosion rate
rather than totally stop the corrosion process. Therefore bond degradation is expected
IPRI/12100/07.01.13

when water penetrates to the interface between the silane coating and the Mg substrate
resulting in detachment of the silane coating. Previous studies have shown that stents will
be encapsulated by neointimal tissue after implantation [37], therefore as long as
detachment occurs after the neointimal formation, silane coating fragments may be
retained and localised rather than being lost into the bloodstream. So the risk associate with
silane coating detachment can be controlled by the development of novel silane coupling
agents with increased bond strength and hydrolytic stability. The two-step coating
procedure reported here aims to combine the advantages of both BTSE and γ-APS to
produce anticorrosive coatings with surface functionality. The chemically bound BTSE layer
introduced in the 1st step coating serves as a hydrophobic barrier, improving the hydrolytic
stability of the silane coating and preventing the underlying Mg from rapid corrosion. This is
clearly demonstrated in the corrosion resistance study (Figure 5 and Figure 6) of the
modified Mg alloys.
Polarization curves of the modified AZ31 Mg alloys are shown in Figure 5 and the corrosion
current (Icorr) values are summarised in Table 1. Compared to bare Mg, the Icorr value
decreased by ~68% for Mg-B, and ~89% for Mg-B-A. As Icorr is directly proportional to the
corrosion rate [38], a distinct improvement in corrosion resistance is indicated. The
corrosion of magnesium involves reaction of H2O with Mg to produce Mg(OH)2 and H2. The
overall reaction includes an anodic (Mg→Mg2++2e-) and cathodic reaction (2H2O+2e→H2+2OH-) [39]. After NaOH passivation, AZ31 surfaces were covered by a layer of Mg(OH)2
film. The metal cation transport dominates the anodic kinetics as the anodic Mg dissolution
reaction occurs on the AZ31 surface underlying the Mg(OH)2 film. The Mg(OH)2 film cannot
stop electrolyte penetration as it is porous and unstable in the aqueous environment. The
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charge transfer associated with the cathodic reaction can occur, both beneath and on top of
the film, which results in a higher cathodic current density compared to silane coated
samples. After BTSE coating, the exchange current density from the cathodic reaction is
reduced because the hydrophobic silane film acts as a physical barrier to retard water
penetration and electron transport. The anodic dissolution reactions rates were also slowed
as the silane coating blocks mass transport of Mg2+ [24]. At the same time, the formation of
Si-O-Mg bonds at the interface also blocks some anodic reactions [24, 31]. The second layer
of γ-APS coating reduces the electrolyte penetration and electron transport process which
further reduces the corrosion current by around one order of magnitude as compared to
uncoated AZ31 samples. The shift of corrosion potential towards the cathodic direction also
indicates that the hydrophobic silane film acts as a physical barrier to retard the electrolyte
penetration [31]. Further modification of Mg-B-A with heparin resulted in an increase in Icorr
from 0.9 µA to 1.87 µA, which may be due to the outer layer silane film being saturated with
the electrolyte during the covalent conjugation process and thus partly losing its function as
a physical barrier to retard the electrolyte penetration [24]. However, even in this case, the
Icorr of Mg-B-A-Heparin is still lower than that of bare AZ31.
The anticorrosive properties of modified AZ31 samples were also assessed by
electrochemical impedance spectroscopy (EIS) (Figure 6). In the whole frequency range
examined, applying the BTSE coating and BTSE-γ-APS coating resulted in a progressive
increase in impedance. Compared to bare AZ31, the impedance of Mg-B-A increased by one
order of magnitude as a result of the non-conductive silane coating, which indicates
effective protection of the metal surface [24]. Similar to the Icorr result, the impedance of
Mg-B-A-heparin sample is reduced to a similar level as that of Mg-B, but is still 4 times
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higher than that of the untreated AZ31 sample. EIS spectra of Mg and Mg-A-B-heparin
samples were also recorded in SBF at 37℃ every 6 h over a 42 h period (Figure 7). Two
capacitive semicircles are clearly observed over the first hour for the uncoated AZ31 and
silane coated samples. For uncoated AZ31 samples, the middle frequency (mf) semicircles
disappeared and a low frequency (lf) inductive loop appears after 6 h immersion indicating
severe pitting corrosion [40]. For silane coated samples (Mg-B-A-heparin), both semicircles
are clearly evident up to 24h immersion, after which time both semicircles appear to merge
into one large semicircle with an associated increase in impedance suggesting improved
corrosion protection [17, 41].
Platelet adhesion behaviour on the modified AZ31 Mg alloys
Compared to the single functional silane coating approach reported previously [16, 17, 42],
this work utilizes BTSE as the first layer of coating to provide a hydrophobic barrier while
minimising the interference from the functional groups (e.g. amino group [23]), which is
important for the improved corrosion resistance of modified AZ31. In addition, the unique
two-step coating offers potential for further modification to improve the biocompatibility of
Mg alloy implants. In this work, heparin has been covalently conjugated onto the modified
Mg surface via the amino groups provided by the grafted γ-APS. The density of surface
accessible heparin, as determined by the TBO assay, is ∼12 µg/cm2 (Figure 8), which is
significantly higher than that of the blank control. This value is comparable to those of
heparin modified surfaces that were shown to effectively improve blood compatibility [30,
43]. To assess whether the heparin retained bioactivity after covalent conjugation, platelet
adhesion assays were performed across different samples. In contrast to the silane modified
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AZ31 samples, significantly lower platelet adhesion was observed on the Mg-B-A-heparin
surface (Figure 9).
Conclusions
Through the route of a two-step coating process, we have developed biofunctionalised,
anticorrosive silane coatings for biodegradable Mg alloys. Compared to bare AZ31 Mg alloy,
Mg-B-A-Heparin exhibits both an improved corrosion resistance and reduced platelet
adhesion. The development of a surface modification strategy that can simultaneously
control the Mg alloy corrosion resistance and inhibit platelet adhesion will inevitably have
major significance for improving the blood compatibility of biodegradable metallic implants.
In addition, this work opens up new avenues and a potential platform to functionalise Mg
alloys based on chemical anchorage and in situ condensation of two types of silanes, a
process which then provides functional groups for the further immobilization of essential
biological components to facilitate the ongoing development of biodegradable metallic
implants.
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Figure 1. A: Hydrolysis process of BTSE; B: Hydrolysis process of γ-APS, and C: Schematic
illustration of the surface modification procedure of AZ31Mg alloy.
Figure 2. FTIR spectra of Mg, Mg-OH, Mg-B and Mg-B-A.
Figure 3. Surface morphologies of AZ31 samples with different treatment: fresh polished Mg
(A), Mg-OH (B), Mg-B (C), Mg-B-A (D) and Mg-B-A-heparin (E).
Figure 4. Static water contact angles of Mg, Mg-OH, Mg-B, Mg-B-A and Mg-B-A-Heparin
samples.
Figure 5. Polarization curves of Mg, Mg-OH, Mg-B, Mg-B-A and Mg-B-A-Heparin samples.
Figure 6. Impedance spectra of Mg, Mg-OH, Mg-B, Mg-B-A and Mg-B-A-heparin samples.
Figure 7.Impedance spectra of Mg and Mg-B-A-heparin samples in SBF solution at 1, 6, 12,
18, 24, 30, 36 and 42h.
Figure 8. Quantitative characterisation of the surface accessible heparins on Mg-B-A and
Mg-B-A-Heparin samples.
Figure 9. Representative SEM micrographs of platelets on Mg-B-A (A) and Mg-B-A-heparin
(B). The scale bars represent 2 µm.

Table 1: Contact angle, surface roughness (Ra), corrosion current (Icorr) and corrosion
resistance (Rp) values of Mg alloy samples after different treatments. The sample size (n) for
roughness and contact angle measurements is 5 and 3 for Icorr and Rp.
Contact angle
Icorr
(˚)
(µA/cm2)

Rp ( ohms/ cm2)

AZ31 Samples

Abbr*.

Ra (nm)

As polished

Mg

148.7±16.5

75.2±2.0

8.32±0.63

2650±538

NaOH passivated

Mg-OH

203.1±6.5

14.4±1.9

5.10±1.42

3178±787

BTSE coated

Mg-B

910.3±2.2

103.2±1.8

2.69±0.31

7788±2572

BTSE+APS coated

Mg-B-A

761.7±51.2

78.2±1.5

0.90±0.24

13635±2745

BTSE+APS+heparin
Mg-B-A2320±57.7
21.4±2.2 1.87±0.23
9515±497
coated
heparin
*Abbr = abbreviation
Table 1: Contact angle, surface roughness (Ra), corrosion current (Icorr) and corrosion
resistance (Rp) values of Mg alloy samples after different treatments. The sample size (n) for
roughness and contact angle measurements is 5 and 3 for Icorr and Rp.
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